{"id":"NCT04201093","sponsor":"AbbVie","briefTitle":"Fixed-Dose Trial in Early Parkinson's Disease (PD)","officialTitle":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson's Disease (TEMPO-1 TRIAL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-12-13","primaryCompletion":"2024-06-28","completion":"2024-06-28","firstPosted":"2019-12-17","resultsPosted":"2025-07-28","lastUpdate":"2025-07-28"},"enrollment":529,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson Disease"],"interventions":[{"type":"DRUG","name":"Tavapadon","otherNames":["PF-06649751","CVL-751"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Tavapadon","otherNames":["PF-06649751","CVL-751"]}],"arms":[{"label":"Tavapadon 5 mg","type":"EXPERIMENTAL"},{"label":"Tavapadon 15 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in participants with early PD.","primaryOutcome":{"measure":"Change From Baseline in the MDS-UPDRS Parts II and III Combined Score","timeFrame":"Week 26","effectByArm":[{"arm":"Placebo","deltaMin":1.8,"sd":0.82},{"arm":"Tavapadon 5 mg","deltaMin":-9.7,"sd":0.86},{"arm":"Tavapadon 15 mg","deltaMin":-10.2,"sd":0.88}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":20},"locations":{"siteCount":77,"countries":["United States","Australia","Bulgaria","Canada","Czechia","France","Germany","Israel","Italy","Poland","Spain","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":175},"commonTop":["NAUSEA","HEADACHE","DIZZINESS","FATIGUE","DYSGEUSIA"]}}